Search results
26 sty 2024 · Identify the varied community-acquired pneumonia presentations to facilitate early and accurate diagnosis. Differentiate between bacterial and viral etiologies of community-aquired pneumonia through a comprehensive assessment of patient history, physical examination findings, and relevant diagnostic tests.
Although up to 18% of patients with community-acquired pneumonia who were hospitalised (admitted to hospital and treated there) have at least one risk factor for immunosuppression worldwide, strong evidence on community-acquired pneumonia management in this population is scarce.
Despite innovative advances in anti-infective therapies and vaccine development technologies, community-acquired pneumonia (CAP) remains the most persistent cause of infection-related mortality globally.
This Review summarizes current evidence on pathogenesis, epidemiology, diagnosis, and treatment of community-acquired pneumonia and focuses on adults.
Abstract. Pneumonia is the leading cause of morbidity and mortality, particularly in old adults. The incidence and etiologic distribution of community-acquired pneumonia is variable both geographically and temporally, and epidemiology might evolve with the change of population characteristics and vaccine uptake rates.
Community-acquired pneumonia (CAP) refers to infections acquired in the community, excluding healthcare-associated disease. Mild cases can be treated successfully at home, but severe cases require hospital admission and are associated with greater cost and suffer higher mortality [ 2 ].
15 paź 2024 · Importance: Community-acquired pneumonia (CAP) results in approximately 1.4 million emergency department visits, 740 000 hospitalizations, and 41 000 deaths in the US annually.
